Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-10-04 | Ms. Huss holds an M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. As a current Chief Executive Officer with more than 22 years of management experience in the medical device industry, and a current and former member of several public and private company boards, Ms. Huss brings to our Board extensive experience in the medical device industry, including experience in the areas of business operations, management and corporate governance. |
| 2019-10-03 | Ms. Huss holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. |
| 2020-10-01 | Ms. Huss holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. She has extensive experience in the medical device industry, including business operations and management. |
| 2021-10-01 | Ms. Huss holds a B.S. in metallurgical engineering from the University of Illinois and a M.S. in technology management from Pepperdine University. |
| 2022-09-30 | Beverly A. Huss has served as a member of our Board since January 2018. From January 2021 to July 2022, Ms. Huss served as the Chief Executive Officer of Pagonia Medical, Inc. ("Pagonia"), a private company focused on creating a novel non-invasive device for the preservation of tissue following a heart attack, stroke, traumatic brain injury and other medical conditions. From September 2013 until December 2020, she served as President and Chief Executive Officer of Qool Therapeutics, Inc. ("Qool"), formerly Thermocure, Inc., a private company focused on temperature management therapies. Prior to joining Qool, Ms. Huss was President and Chief Executive Officer at start-up medical device company Vibrynt, Inc., and held multiple senior level leadership positions at Guidant Corporation, a public company that designs and manufactures cardiovascular products, including, most recently President, Endovascular Solutions, Vice President, Global Marketing, Vascular Intervention and Vice President of the Stent Business Unit. Ms. Huss has served on the board of directors of Madorra Inc. (as Executive Chair), a privately-held medical device company developing solutions to improve quality of life after menopause, since October 2017; Iridex Corporation, a public medical device company, since March 2022; and Ancora Heart, Inc., a privately-held medical device company developing heart failure treatments, since June 2021. Her prior private company board experience includes Pagonia Medical, Inc., Coala Life, Inc., Artes Medical, Inc., Wright Medical Group, Inc., and Dade Behring Holdings, Inc. Ms. Huss holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. |
| 2023-09-29 | Ms. Huss holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. |
| 2024-10-04 | Ms. Huss holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. |
| Filing Date | Source Excerpt |
|---|---|
| 2024-04-10 | Ms. Huss holds a B.S. in metallurgical engineering from the University of Illinois and a M.S. in technology management from Pepperdine University. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-29 | Beverly A. Huss has served as a director of the Company since March 2022. The Audit Committee of the Board consists of Mr. Ludlum, Ms. Devi, and Ms. Huss. The Compensation Committee of the Board consists of Ms. Huss, Mr. Shuda, and Dr. Grove. The following table provides information concerning the compensation paid by us to each of our non-employee directors for fiscal 2021. Beverly A. Huss was appointed to the Board in 2022 and no compensation for 2021 is listed. |
| 2023-04-28 | Beverly A. Huss has served as a director of the Company since March 2022. The Audit Committee of the Board consists of Mr. Ludlum, Ms. Devi, and Ms. Huss. The Compensation Committee of the Board consists of Ms. Huss, Mr. Shuda, and Dr. Grove. |
| 2024-04-29 | The Audit Committee of the Board currently consists of Mr. Ludlum, Ms. Devi, and Ms. Huss. The Compensation Committee of the Board currently consists of Ms. Huss, Mr. Shuda, and Dr. Grove. The Nominating and Governance Committee of the Board currently consists of Mr. Ludlum, Dr. Grove, Mr. Shuda, and Ms. Devi. Ms. Huss is a member of the Audit Committee, Compensation Committee, and Nominating and Governance Committee. Director Compensation for 2023: Beverly A. Huss total $127,499. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22